506 related articles for article (PubMed ID: 20633037)
1. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
2. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
3. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.
Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE
Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791
[TBL] [Abstract][Full Text] [Related]
4. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
5. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
[TBL] [Abstract][Full Text] [Related]
6. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats.
Reissmüller E; Ebert U; Löscher W
Epilepsia; 2000 Apr; 41(4):372-9. PubMed ID: 10756400
[TBL] [Abstract][Full Text] [Related]
9. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
10. Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study.
Kurth C; Schäuble B; Schreiner A; Rettig K; Steinhoff BJ
Acta Neurol Scand; 2009 Aug; 120(2):80-7. PubMed ID: 19432934
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.
Milligan TA; Hurwitz S; Bromfield EB
Neurology; 2008 Aug; 71(9):665-9. PubMed ID: 18725591
[TBL] [Abstract][Full Text] [Related]
12. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
[TBL] [Abstract][Full Text] [Related]
13. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
[TBL] [Abstract][Full Text] [Related]
14. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
Majkowski J; Neto W; Wapenaar R; Van Oene J
Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
16. Topiramate in refractory epilepsy: a prospective observational study.
Stephen LJ; Sills GJ; Brodie MJ
Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
[TBL] [Abstract][Full Text] [Related]
18. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
19. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
[TBL] [Abstract][Full Text] [Related]
20. Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy.
Fröscher W; Schier KR; Hoffmann M; Meyer A; May TW; Rambeck B; Rösche J
Epileptic Disord; 2005 Sep; 7(3):237-48. PubMed ID: 16162434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]